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background:  We aim to evaluate the impact of several drugs on long-term all-cause mortality and risk of stroke or transient ischemic 
attack (TIA), in patients hospitalized for atrial fibrillation (AF).
Methods:  Using Quebec provincial health administrative databases, we conducted a retrospective cohort study of all patients aged 
≥65 years hospitalized in Quebec for a primary diagnosis of AF between 1998 to 2002. The primary endpoint was all-cause mortality; 
the secondary endpoint was hospitalization for stroke/TIA. We used multivariate regression Cox proportional hazards to determine the 
independent risks associated with the use of beta-blockers, calcium channel blockers (CCB), diuretics, statins, ACE-I/ARBs, warfarin, 
digoxin, and antiarrhythmic drugs for both endpoints.
results:  A total of 10,158 patients (mean age of 76.5 years, 59% females) were included in the analysis. For the primary endpoint, 
the median follow-up period was 6.5 years (IQR 2.8, 10.4). At baseline, 65.6% of patients were hypertensive and 19.8% of patients 
had diabetes mellitus. There was a history of prior stroke or TIA in 10.1% of patients. A history of CAD was present in 53.5% of patients 
hospitalized for AF, of which 29.3% had prior MI. The use of beta-blockers, statins, warfarin and antiarrythmics were all associated with 
lower all-cause mortality (Table 1), while diuretics and digoxin were associated with increased mortality. Warfarin was the only drug 
associated with decreased risk of hospitalization for stroke/TIA.
 
